Back

ESMO Plenary Feb 2023 - ESMO Virtual Plenaries: Feb 2023

Feb 16 - Feb 17, 2023 | LuganoSwitzerland

LARVOL is not affiliated with ESMO Virtual Plenaries: Feb 2023 and all trademarks, logos, and brand names are property of their respective owners

Top Trials
Condition
Product
MOA
Trial Name/ID

Showing 1 titles linked to Trials

Pembrolizumab (pembro) plus chemotherapy (chemo) as first-line therapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Phase III KEYNOTE-859 study

21 Twitter Reactions